419 related articles for article (PubMed ID: 16284907)
1. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.
Miller DW; Johnson JM; Solano SM; Hollingsworth ZR; Standaert DG; Young AB
J Neural Transm (Vienna); 2005 Dec; 112(12):1613-24. PubMed ID: 16284907
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein mRNA expression in oligodendrocytes in MSA.
Asi YT; Simpson JE; Heath PR; Wharton SB; Lees AJ; Revesz T; Houlden H; Holton JL
Glia; 2014 Jun; 62(6):964-70. PubMed ID: 24590631
[TBL] [Abstract][Full Text] [Related]
3. Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy.
Jin H; Ishikawa K; Tsunemi T; Ishiguro T; Amino T; Mizusawa H
J Med Dent Sci; 2008 Mar; 55(1):145-53. PubMed ID: 19845160
[TBL] [Abstract][Full Text] [Related]
4. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
5. Role of transcriptional control in multiple system atrophy.
Chen J; Mills JD; Halliday GM; Janitz M
Neurobiol Aging; 2015 Jan; 36(1):394-400. PubMed ID: 25218777
[TBL] [Abstract][Full Text] [Related]
6. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
[TBL] [Abstract][Full Text] [Related]
7. SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy.
Kon T; Forrest SL; Lee S; Li J; Chasiotis H; Nassir N; Uddin MJ; Lang AE; Kovacs GG
Neurobiol Dis; 2024 Aug; 198():106551. PubMed ID: 38839023
[TBL] [Abstract][Full Text] [Related]
8. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
Stemberger S; Poewe W; Wenning GK; Stefanova N
Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
[TBL] [Abstract][Full Text] [Related]
9. Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis.
Fellner L; Buchinger E; Brueck D; Irschick R; Wenning GK; Stefanova N
BMC Neurosci; 2018 May; 19(1):32. PubMed ID: 29783943
[TBL] [Abstract][Full Text] [Related]
10. Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications.
Schafferer S; Khurana R; Refolo V; Venezia S; Sturm E; Piatti P; Hechenberger C; Hackl H; Kessler R; Willi M; Gstir R; Krogsdam A; Lusser A; Poewe W; Wenning GK; Hüttenhofer A; Stefanova N
PLoS One; 2016; 11(3):e0150705. PubMed ID: 26962858
[TBL] [Abstract][Full Text] [Related]
11. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy.
Ozawa T; Okuizumi K; Ikeuchi T; Wakabayashi K; Takahashi H; Tsuji S
Acta Neuropathol; 2001 Aug; 102(2):188-90. PubMed ID: 11563635
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
Wang Y; Lü C; Ye Z
Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
[TBL] [Abstract][Full Text] [Related]
14. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
[TBL] [Abstract][Full Text] [Related]
15. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
[TBL] [Abstract][Full Text] [Related]
16. The role of alpha-synuclein in the pathogenesis of multiple system atrophy.
Wenning GK; Jellinger KA
Acta Neuropathol; 2005 Feb; 109(2):129-40. PubMed ID: 15666181
[TBL] [Abstract][Full Text] [Related]
17. Multiple system atrophy: alpha-synuclein and neuronal degeneration.
Yoshida M
Neuropathology; 2007 Oct; 27(5):484-93. PubMed ID: 18018485
[TBL] [Abstract][Full Text] [Related]
18. Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.
Kaji S; Maki T; Ishimoto T; Yamakado H; Takahashi R
Transl Neurodegener; 2020; 9():7. PubMed ID: 32095235
[TBL] [Abstract][Full Text] [Related]
19. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.
Armstrong RA; Cairns NJ; Lantos PL
Parkinsonism Relat Disord; 2006 Sep; 12(6):356-62. PubMed ID: 16723266
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions.
Huang Y; Song YJ; Murphy K; Holton JL; Lashley T; Revesz T; Gai WP; Halliday GM
Acta Neuropathol; 2008 Dec; 116(6):639-46. PubMed ID: 18936941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
